Institutes
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
July 6, 2021
Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students
New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.
July 2, 2021
Departments of Geriatrics and Pediatrics Win First Place in Quality Improvement Program
Faculty from UAMS’ Departments of Geriatrics and Pediatrics garnered first place in the Quality Improvement for Advanced Learners Program (QIALP) for their exploration of racial disparity in screening methods among dementia patients.
July 1, 2021
UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders
LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…
June 29, 2021
UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic
LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
June 23, 2021
UAMS Thomas and Lyon Longevity Clinic Recognized as Age-Friendly Health System
LITTLE ROCK — The UAMS Thomas and Lyon Longevity Clinic in the Donald W. Reynolds Institute on Aging has successfully attained Level I Certification as an Age-Friendly Health System.
June 21, 2021
‘Women Helping Women’ Art Donations Adorn Walls of Newly Opened UAMS Breast Center
The first piece that went up for sale one late afternoon in early April couldn’t have been more aptly named. “Hope Blooms,” shows a bouquet of colorful flowers, appearing to burst forth from a blue glass jar. Artist Morgan Coven Herndon’s 48 x 48-inch acrylic and latex on gallery-wrapped canvas was $850 plus tax. It…
June 3, 2021
UAMS Donald W. Reynolds Institute on Aging Receives $1.9 Million Grant to Research Link Between Blood Sugar, Alzheimer’s Disease
The Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) has been awarded a five-year, $1.9 million grant from the National Institute on Aging, a division of the National Institutes of Health.
June 1, 2021
Jenkins to Help Lead Clinical Trials Expansion at UAMS Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Amy Jo Jenkins, M.S., CCRP, recently joined the Winthrop P. Rockefeller Cancer Institute’s new Office of Clinical Trials Administration and will lead the Early Phase Clinical Trials at the University of Arkansas for Medical Sciences (UAMS).
Previous page Next page